Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications
Performance of Google NotebookLM for AI-assisted data extraction and consensus statement generation in a heterogenous systematic review on inflammatory bowel disease, obesity, and cardiometabolic comorbidities: A Methodological Report.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026
Beyond calprotectin: where leucine-rich α2-glycoprotein may fit in small bowel Crohn disease monitoring.
Journal: Inflammatory bowel diseases
Published: June 30, 2026
Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness method.
Journal: BMJ open
Published: May 26, 2026
Advancing Equity and Patient Partnership in Clinical Trials for Inflammatory Bowel Disease: A Model for Inclusive Trial Design.
Journal: Clinical and experimental gastroenterology
Published: March 03, 2026
The role of glucagon-like peptide 1 receptor agonists in the management of patients with inflammatory bowel diseases.
Journal: Inflammatory bowel diseases
Published: February 11, 2026
Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): Consensus on Obesity and Cardiometabolic Comorbidities in Inflammatory Bowel Disease using Evidence Synthesis and the RAND/UCLA Appropriateness Method.
Journal: medRxiv : the preprint server for health sciences
Published: January 02, 2026
The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results From the Phase II GLADIATOR Trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 22, 2025
The association between 6-thioguanine nucleotide levels, adalimumab exposure, immune response, and drug clearance.
Journal: Crohn's & colitis 360
Published: November 27, 2025
Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials.
Journal: Inflammatory bowel diseases
Published: October 02, 2025
Real-World Effectiveness of Upadacitinib for Perianal Crohn's Disease: A Multicenter Retrospective Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 20, 2025
Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials.
Journal: United European gastroenterology journal
Published: September 02, 2025
A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn's disease.
Journal: Journal of Crohn's & colitis
Published: April 28, 2025
Last Updated: 09/26/2026